Wolfgang Reindl

6.3k total citations · 1 hit paper
111 papers, 4.5k citations indexed

About

Wolfgang Reindl is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Wolfgang Reindl has authored 111 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 28 papers in Immunology and 25 papers in Surgery. Recurrent topics in Wolfgang Reindl's work include Inflammatory Bowel Disease (17 papers), Immune Cell Function and Interaction (15 papers) and Microscopic Colitis (11 papers). Wolfgang Reindl is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Immune Cell Function and Interaction (15 papers) and Microscopic Colitis (11 papers). Wolfgang Reindl collaborates with scholars based in Germany, United States and Switzerland. Wolfgang Reindl's co-authors include Thorsten Berg, Anne Krug, Klaus Strebhardt, Roland M. Schmid, Shizuo Akira, Roland M. Schmid, Wolfgang Huber, Marina Lesina, Akihiko Yoshimura and Juping Yuan and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Wolfgang Reindl

106 papers receiving 4.4k citations

Hit Papers

Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Pr... 2011 2026 2016 2021 2011 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Reindl Germany 37 1.6k 1.5k 1.1k 983 533 111 4.5k
Thomas Geiger Germany 26 1.3k 0.8× 1.8k 1.2× 986 0.9× 358 0.4× 641 1.2× 70 4.6k
Terrence A. Barrett United States 42 1.9k 1.2× 1.5k 1.0× 970 0.9× 679 0.7× 684 1.3× 137 5.1k
Frank Schmitz Germany 38 2.2k 1.4× 1.4k 0.9× 894 0.8× 826 0.8× 676 1.3× 123 4.7k
Alejandro Zentella‐Dehesa Mexico 32 1.6k 1.0× 3.3k 2.1× 975 0.9× 499 0.5× 833 1.6× 140 6.7k
Toru Kubota Japan 47 1.5k 0.9× 2.8k 1.8× 816 0.7× 1.1k 1.1× 1.4k 2.6× 172 7.9k
Thomas Weichhart Austria 38 2.1k 1.3× 2.1k 1.4× 598 0.5× 593 0.6× 994 1.9× 83 5.9k
Juan Zhang China 39 2.5k 1.6× 3.2k 2.1× 520 0.5× 552 0.6× 610 1.1× 211 6.5k
Tonino Alonzi Italy 35 1.0k 0.7× 1.7k 1.1× 916 0.8× 387 0.4× 796 1.5× 70 4.2k

Countries citing papers authored by Wolfgang Reindl

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Reindl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Reindl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Reindl more than expected).

Fields of papers citing papers by Wolfgang Reindl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Reindl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Reindl. The network helps show where Wolfgang Reindl may publish in the future.

Co-authorship network of co-authors of Wolfgang Reindl

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Reindl. A scholar is included among the top collaborators of Wolfgang Reindl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Reindl. Wolfgang Reindl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Centeno, A., et al.. (2025). Emerging microbiome-directed therapies in inflammatory bowel disease: beyond diet modification and FMT. Seminars in Immunopathology. 47(1). 42–42.
2.
Augustin, Robert, Anouk Oldenburger, Jens Markus Borghardt, et al.. (2025). Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide. Molecular Metabolism. 99. 102205–102205. 1 indexed citations
3.
Reindl, Wolfgang, et al.. (2025). Role of the gut microbiome in psychological symptoms associated with inflammatory bowel diseases. Seminars in Immunopathology. 47(1). 12–12. 1 indexed citations
4.
Bekrater‐Bodmann, Robin, et al.. (2024). Body Evaluation and Body Ownership in Patients with Inflammatory Bowel Disease: the Role of Interoceptive Sensibility and Childhood Maltreatment. International Journal of Behavioral Medicine. 32(6). 821–833.
5.
Thomann, A, Mike M. Schmitgen, Matthias P. Ebert, et al.. (2024). Associations Between Brain Morphology, Inflammatory Markers, and Symptoms of Fatigue, Depression, or Anxiety in Active and Remitted Crohn’s Disease. Journal of Crohn s and Colitis. 18(11). 1767–1779. 5 indexed citations
7.
Thomann, A, Torsten Wüstenberg, Jakob Wirbel, et al.. (2022). Depression and fatigue in active IBD from a microbiome perspective—a Bayesian approach to faecal metagenomics. BMC Medicine. 20(1). 366–366. 34 indexed citations
8.
Thomann, A, et al.. (2022). P232 Depression and fatigue in active IBD from a microbiome perspective - a bayesian approach to faecal metagenomics. Journal of Crohn s and Colitis. 16(Supplement_1). i280–i282. 1 indexed citations
9.
Globig, Anna-Maria, Katharina Wild, Katharina Zoldan, et al.. (2020). Ustekinumab Inhibits T Follicular Helper Cell Differentiation in Patients With Crohn’s Disease. Cellular and Molecular Gastroenterology and Hepatology. 11(1). 1–12. 18 indexed citations
10.
Hoffmann, Péter, Anna-Maria Globig, A Thomann, et al.. (2020). Tofacitinib in Treatment-Refractory Moderate to Severe Ulcerative Colitis: Real-World Experience from a Retrospective Multicenter Observational Study. Journal of Clinical Medicine. 9(7). 2177–2177. 24 indexed citations
11.
Winter, Martin, Robert Ries, Markus Zeeb, et al.. (2020). MALDI-TOF-Based Affinity Selection Mass Spectrometry for Automated Screening of Protein–Ligand Interactions at High Throughput. SLAS DISCOVERY. 26(1). 44–57. 18 indexed citations
12.
Thomann, A, Mike M. Schmitgen, Matthias Ebert, et al.. (2020). Exploring joint patterns of brain structure and function in inflammatory bowel diseases using multimodal data fusion. Neurogastroenterology & Motility. 33(6). e14078–e14078. 33 indexed citations
13.
Winter, Martin, Robert Ries, Gisela Schnapp, et al.. (2019). MALDI-TOF Mass Spectrometry-Based High-Throughput Screening for Inhibitors of the Cytosolic DNA Sensor cGAS. SLAS DISCOVERY. 25(4). 372–383. 34 indexed citations
14.
Galata, Christian, Daniela Hirsch, Wolfgang Reindl, et al.. (2017). Clinical and Histopathologic Features of Colorectal Adenocarcinoma in Crohn’s Disease. Journal of Clinical Gastroenterology. 52(7). 635–640. 9 indexed citations
15.
Yuan, Juping, Mourad Sanhaji, Andrea Krämer, et al.. (2011). Polo-Box Domain Inhibitor Poloxin Activates the Spindle Assembly Checkpoint and Inhibits Tumor Growth in Vivo. American Journal Of Pathology. 179(4). 2091–2099. 75 indexed citations
16.
Reindl, Wolfgang, Klaus Strebhardt, & Thorsten Berg. (2011). A Fluorescence Polarization Assay for the Discovery of Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1. Methods in molecular biology. 795. 69–81. 4 indexed citations
17.
18.
19.
Voland, Petra, Susanne Schwendy, Roland Rad, et al.. (2004). Human Dendritic Cells Respond to Helicobacter pylori , Promoting NK Cell and Th1-Effector Responses In Vitro. The Journal of Immunology. 173(2). 1249–1257. 103 indexed citations
20.
Schulte‐Frohlinde, Ewert, Wolfgang Reindl, C. Lersch, et al.. (2000). Effects of oral casokefamide on plasma levels, tolerance, and intestinal transit in man. Peptides. 21(3). 439–442. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026